Minimizing minimally invasive surgery: Current status of the single-port robotic surgery in Urology.
Actas Urol Esp (Engl Ed)
; 45(5): 345-352, 2021 Jun.
Article
in En, Es
| MEDLINE
| ID: mdl-34088433
ABSTRACT
BACKGROUND:
The novel da Vinci Single-Port (SP) robotic platform received the US FDA approval in 2018. The device, specifically conceived for single-site approach, is pushing through the limits of minimally invasive surgery. We sought to provide a comprehensive overview of the current status of the clinical experiences accomplished by the da Vinci SP in urology, and to discuss future perspectives.METHODS:
A non-systematic literature review was performed focusing on single port articles in urological surgery using Medline/PubMed and Embase search electronic engines. The authors analyzed findings and a brief report of the clinical experience for surgical procedures completed by the SP platform was described.RESULTS:
The current data available from single-port robotic established the safety and feasibility of urologic procedures using this novel platform. However, the results come from single-center case series, small cohorts and retrospective studies that need to be cautiously interpreted. Additional evidence is required to determine the asset of the SP platform in the urological community.CONCLUSIONS:
The SP robotic system opens new frontiers on the surgical scenery facilitating the completion of urological surgeries through a single incision. Further comparative studies will be required to assess perioperative and long-term oncological and functional outcomes among SP, multi-arm robotic and open approaches.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urology
/
Robotic Surgical Procedures
Type of study:
Observational_studies
/
Systematic_reviews
Language:
En
/
Es
Journal:
Actas Urol Esp (Engl Ed)
Year:
2021
Document type:
Article